What researchers published on Fabry-betegség
2563 papers, newest first.
Showing 40 of 2563
Esetismertetés[A novel GLA variant in classic Fabry disease: a case report].Zhonghua nei ke za zhi
Generation of an induced pluripotent stem cell line from a Fabry disease patient carrying the GLA c.640-801G>A mutation.Stem cell research
Megfigyeléses vizsgálatAnti-Drug Antibodies in Patients with Fabry Disease Treated with Agalsidase-Alpha or -Beta: A Retrospective Italian Multicenter Study.Cells
AAV-mediated genome targeting of the GLA cDNA in newborn and juvenile Gla KO mice achieves long-term correction of Fabry disease.Molecular therapy. Advances
Improving molecular diagnosis of fabry disease: functional validation of novel splicing variants in GLA.Orphanet journal of rare diseases
ÁttekintésImplementing evolving Fabry disease management recommendations in resource-constrained settings: lessons from South Africa.Orphanet journal of rare diseases
Leadless Pacemaker Implantation in Fabry Disease With Permanent Atrial Fibrillation and Bradycardia: Diagnostic and Implantation Guidance by Preprocedural Cardiac Magnetic Resonance Imaging.Clinical case reports
Raised Amylase as a Potential Marker of Vascular Dysfunction and Inflammation in Fabry Disease.JIMD reports
Early Change in Left Ventricular Global Longitudinal Strain and Long-Term Cardiovascular Outcomes in Fabry Disease: A Prognostic Tool for Enzyme Replacement Therapy.JACC. Cardiovascular imaging
Migalastat Versus Enzyme Replacement Therapy in Treatment-Naïve Fabry Disease: Real-World Evidence From the followME Fabry Pathfinders Registry.Journal of inherited metabolic disease
Relative versus absolute globotriaosylsphingosine changes and kidney outcomes in Fabry disease.Molecular genetics and metabolism reports
EsetismertetésVentricular tachycardia ablation in late-onset phenotype Fabry disease: a case report.European heart journal. Case reports
Impact of Anti-drug Antibodies in Patients with Fabry Disease under Enzyme Replacement Therapy: Long-Term Outcomes.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Megfigyeléses vizsgálatDisease severity and lyso-Gb3 are associated with early echocardiographic markers of cardiac involvement in Fabry disease: a single-center observational study.Orphanet journal of rare diseases
Peripheral and cardiac determinants of exercise intolerance in classic Anderson-Fabry disease: insights from cardiopulmonary exercise testing and advanced echocardiography.Orphanet journal of rare diseases
Biochemical Endocrine and Skeletal Findings in Adults with Fabry Disease: A Descriptive Single-Center Study.Biomolecules
Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: Lessons from the Fabry heart.Cell reports
EsetismertetésFabry's Disease, Valvular Disease and Infective Endocarditis: A Rare Intersection.JACC. Case reports
"On-Site Family Screening" in Fabry Disease: An Innovative Model for Identifying At-Risk Relatives.Journal of clinical medicine
Heterogeneous biochemical responses to migalastat in real-world cases of Fabry disease.European journal of medical genetics
Impact of the protein corona in RGD-functionalized nanoliposomes delivering enzymatic replacement therapy for Fabry disease.International journal of pharmaceutics
EsetismertetésSilent Cardiac Progression in a Woman With Fabry Disease Despite Normal Baseline CMR.JACC. Case reports
ÁttekintésThe role of dermatological manifestations in the early diagnosis of Fabry disease: a scoping review.Frontiers in medicine
ÁttekintésThyroid involvement in lysosomal storage diseases: current evidence and clinical perspectives.Reviews in endocrine & metabolic disorders
Screening of fabry disease in patients with left ventricular hypertrophy: a single-center study in Mexico.Orphanet journal of rare diseases
Esetismertetés[Fabry disease misdiagnosed as obstructive hypertrophic cardiomyopathy: a case report].Zhonghua xin xue guan bing za zhi
NF-κB p65 iso5 Δ6/7 and p65 iso5 Δ10 isoforms drive immune-inflammatory remodeling in Fabry disease and GLA variants of uncertain significance.Frontiers in immunology
[Fabry disease and hypertrophic obstructive cardiomyopathy: from phenotypic mimicry to precision diagnosis and treatment].Zhonghua xin xue guan bing za zhi
Prevalence of migalastat-amenable variants in patients with Fabry disease from Brazil, Argentina, and Colombia: an observational study.Frontiers in genetics
Myosin inhibitor therapy in Fabry cardiomyopathy with dynamic left ventricular outflow obstruction.American heart journal plus : cardiology research and practice
Clinical and Laboratory Characteristics of Fabry Disease in Children and Adults: A Focus on Early Kidney Findings.Journal of clinical medicine
Molecular and Structural Characterization of Five Novel GLA Gene Variants in Fabry Disease.International journal of molecular sciences
NGAL as a Biomarker of Tubular Injury and Glomerular Dysfunction in Fabry Nephropathy.Cells
ÁttekintésNovel GLA Variants: 10 Experts' Tips for the Clinical Assessment of Fabry Disease.Journal of clinical medicine
Safety, Efficacy, and Pharmacokinetics of Agalsidase Alfa in Treatment-Naive Chinese Patients with Fabry Disease: 52-Week Phase 3, Open-Label, Single-Arm Study.Advances in therapy
EsetismertetésCase Report: Fabry cardiomyopathy associated with a novel truncating GLA variant, c.837_838delinsAT, p.(Gln280Ter).Frontiers in medicine
Megfigyeléses vizsgálatLongitudinal assessment of the retinal phenotype in patients with Fabry disease undergoing continuous enzyme replacement and/or chaperone therapy.Orphanet journal of rare diseases
EsetismertetésPediatric Fabry disease revealed by early neuropathic symptoms: a case report.Oxford medical case reports
Multicentric screening for Fabry disease in patients with kidney replacement therapy in the Italian Region of Veneto.Minerva urology and nephrology
Genome sequencing reveals the prevalence of Fabry disease-causing variants in Japan: Evidence from the Tohoku Medical Megabank.Genetics in medicine open